LifePoint Health Inc (NASDAQ:LPNT) has received a consensus recommendation of “Hold” from the eighteen brokerages that are presently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, fifteen have given a hold rating and one has issued a buy rating on the company. The average 1-year price objective among analysts that have covered the stock in the last year is $58.45.
LPNT has been the topic of a number of research analyst reports. BidaskClub downgraded LifePoint Health from a “strong-buy” rating to a “buy” rating in a report on Friday, November 2nd. Zacks Investment Research cut LifePoint Health from a “buy” rating to a “hold” rating in a research report on Tuesday, October 23rd. Finally, William Blair reissued a “hold” rating on shares of LifePoint Health in a research report on Friday, August 17th.
Shares of LPNT stock remained flat at $$64.99 during midday trading on Thursday. LifePoint Health has a 52 week low of $41.45 and a 52 week high of $65.35. The company has a current ratio of 1.85, a quick ratio of 1.63 and a debt-to-equity ratio of 1.22. The firm has a market cap of $2.52 billion, a PE ratio of 17.90, a PEG ratio of 1.73 and a beta of 0.51.
Several institutional investors and hedge funds have recently modified their holdings of the company. BlackRock Inc. boosted its position in shares of LifePoint Health by 29.9% in the 2nd quarter. BlackRock Inc. now owns 4,474,205 shares of the company’s stock worth $218,340,000 after purchasing an additional 1,030,415 shares in the last quarter. Vanguard Group Inc. lifted its position in LifePoint Health by 2.3% in the 3rd quarter. Vanguard Group Inc. now owns 3,443,990 shares of the company’s stock valued at $221,793,000 after acquiring an additional 78,594 shares in the last quarter. JPMorgan Chase & Co. lifted its position in LifePoint Health by 229.8% in the 3rd quarter. JPMorgan Chase & Co. now owns 1,375,470 shares of the company’s stock valued at $88,580,000 after acquiring an additional 958,353 shares in the last quarter. Boston Partners lifted its position in LifePoint Health by 2.8% in the 2nd quarter. Boston Partners now owns 873,008 shares of the company’s stock valued at $42,603,000 after acquiring an additional 24,086 shares in the last quarter. Finally, Water Island Capital LLC bought a new position in LifePoint Health in the 3rd quarter valued at approximately $44,178,000. 94.63% of the stock is currently owned by hedge funds and other institutional investors.
About LifePoint Health
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers, and post-acute facilities in the United States. Its hospitals provide a range of medical and surgical services, such as general surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, rehabilitation, and pediatric, as well as specialized services, including open-heart surgery, skilled nursing, psychiatric care, and neuro-surgery.
Read More: Reverse Stock Split
Receive News & Ratings for LifePoint Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health and related companies with MarketBeat.com's FREE daily email newsletter.